Latest News

Dec 13, 2007

Health Enhancement Products signs contract with Specialty Nutrition Group, Inc for Re-Branding and Product Marketing of ProAlgaZyme.


Nov 14, 2007

Health Enhancement Products Announced the Long Awaited Discovery of a Class of "Orally Active Agents" in Its Primary Product, ProAlgaZyme


Nov 6, 2007

Health Enhancement Products Reports Results in the Second Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial


Oct 25, 2007

Health Enhancement Products Reports Results in Testing of the ProAlgaZyme Clinical Lot Used in the Suspended Clinical Trial



Health Enhancement Products is a member of these organizations







 
Health Enhancement Products Announces Marketing and Distribution Agreement with Suarez Corporation Industries


Thursday November 17, 6:30 am ET

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Nov. 17, 2005--Health Enhancement Products, Inc. (OTCBB: HEPI - News ) announced today it has signed a contract with Suarez Corporation Industries, Inc., ("SCI"), a diversified distribution company based in North Canton, Ohio. The Testing Agreement gives Suarez the exclusive right to test market the ProAlgaZyme product, as a dietary supplement/weight loss product, for a period of six weeks. Suarez intends to test market HEPI's ProAlgaZyme product under the private label "AlgaHEALTH." During the six-week testing phase, SCI is expected to advertise in several different mediums with varying ads to determine which ads and which demographics are best for the sale of the product. SCI will purchase from HEPI any ProAlgaZyme product required in connection with the test marketing. If the marketing proves successful, HEPI has agreed to negotiate a potential exclusive contract with SCI for the sale of the ProAlgaZyme product (under private label) as a weight loss product. HEPI would require that any exclusive arrangement be based on guaranteed minimum revenues to HEPI.

Howard R. Baer, Chairman of HEPI, stated, "I'm very pleased to be working with a distribution company as knowledgeable and experienced as Suarez. Suarez has brought several other products to market, the same way they are taking AlgaHEALTH out, that ended up being sold through major retail drug store and health store chains. Based upon our internal research and external clinical studies, we believe that ProAlgaZyme has demonstrated good potential as a weight loss product."

Ben Suarez, President of Suarez Corporation Industries, stated, "I am looking forward to marketing Health Enhancement Products' ProAlgaZyme product under our over-the-counter trade name of AlgaHEALTH. We will be capitalizing a $200,000 testing project which will determine the consumer marketing viability of AlgaHEALTH. If these tests prove to be successful, past history suggests that Suarez should be able to distribute millions of bottles per year of AlgaHEALTH via direct marketing and in our network of drug stores. Presently, nationwide, SCI's products are in over 30,000 drug stores and other stores that carry health products."

Suarez Corporation Industries (SCI) is a 37-year-old diversified marketing company with a 170,000-square-foot building complex located in Canton, Ohio. The company, which has revenues in excess of $100 million a year, markets to customers through mail, phone and Internet, as well as television, newspaper, magazines and retail. Suarez is known in the industry for its advanced marketing methods and capabilities.

Health Enhancement Products, Inc. (OTCBB: HEPI - News ) is a neutraceutical company engaged in the development of a supplementary health-enhancing product using only pure, all-natural ingredients.

The Company's sole product is ProAlgaZyme, a health-enhancing water that is produced from an algae grown in 100% distilled water. The algae produce a protein, most likely as a means of protecting itself from exposure to outside disease and harmful bacteria. The protein solution is then drawn off, filtered, tested and bottled for consumption. Recent studies performed by the Company have indicated that ProAlgaZyme supports a compromised immune system.

Except for any historical information, the matters discussed in this press release contain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements involve risks and uncertainties. A number of factors could cause actual results to differ from those indicated in the forward-looking statements, including the company's ability to fund its operations and market and sell its ProAlgaZyme product. Further, the amount of product, if any, Suarez purchases from HEPI will depend upon, among other things, market acceptance of the product and the level of sales of the product Suarez is able to achieve under the AlgaHEALTH private label. All forward-looking statements are subject to a number of assumptions, risks and uncertainties. Readers are cautioned that such statements are not guarantees of future performance and that actual results or developments may differ materially from those set forth in the forward-looking statements. The company undertakes no obligation to publicly update or revise forward-looking statements, whether as a result of new information or otherwise.


Contact:

Health Enhancement Products, Inc.
Howard R. Baer,
480-385-3800
www.heponline.com
 


© 2007 HEALTH ENHANCEMENT PRODUCTS INC.
            PRIVACY POLICY           DISCLAIMER 

 

v5Design.Com